Kairong Shi
- Biomaterials top 1%
- Molecular Biology top 10%
- Biomedical Engineering top 5%
- Oncology
- Materials Chemistry
- Topics
- Nanoparticle-Based Drug Delivery (21 papers)RNA Interference and Gene Delivery (16 papers)Nanoplatforms for cancer theranostics (12 papers)
- Partner nations
- China
In The Last Decade
Kairong Shi
25 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 83
- Biomaterials 851
- Molecular Biology 825
- Biomedical Engineering 657
- Oncology 141
- Materials Chemistry 111
Countries citing papers authored by Kairong Shi
This map shows the geographic impact of Kairong Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kairong Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kairong Shi more than expected).
Fields of papers citing papers by Kairong Shi
This network shows the impact of papers produced by Kairong Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kairong Shi. The network helps show where Kairong Shi may publish in the future.
Co-authorship network of co-authors of Kairong Shi
This figure shows the co-authorship network connecting the top 25 collaborators of Kairong Shi. A scholar is included among the top collaborators of Kairong Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kairong Shi. Kairong Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 46 | |
| 2 | 59 | |
| 3 | 40 | |
| 4 | 26 | |
| 5 | 35 | |
| 6 | 13 | |
| 7 | 5 | |
| 8 | 13 | |
| 9 | 52 | |
| 10 | 20 | |
| 11 | 70 | |
| 12 | 41 | |
| 13 | 96 | |
| 14 | 86 | |
| 15 | 55 | |
| 16 | 63 | |
| 17 | 90 | |
| 18 | 69 | |
| 19 | 47 | |
| 20 | 31 |
About Kairong Shi
Kairong Shi is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology, having authored 25 papers that have together received 1.4k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (21 papers), RNA Interference and Gene Delivery (16 papers) and Nanoplatforms for cancer theranostics (12 papers). The work is most often cited by research in Biomaterials (851 citations), Biomedical Engineering (657 citations) and Pharmaceutical Science (83 citations). Kairong Shi has collaborated with scholars based in China. Frequent co-authors include Qin He, Huile Gao, Zhirong Zhang, Qianyu Zhang, Xingli Cun, Ling Mei, Xian Tang, Yayuan Liu, Qianwen Yu and Shaobo Ruan. Their work appears in journals such as ACS Nano, Biomaterials and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.